Valuation: Biogen Inc.

Market Cap 30.37B 26.64B 24.59B 22.72B 43.07B 2,908B 43.93B 296B 115B 1,423B 114B 112B 4,940B P/E 2026 *
31.3x
P/E 2027 * 17.2x
Enterprise Value 35.88B 31.47B 29.05B 26.85B 50.89B 3,435B 51.9B 349B 136B 1,681B 135B 132B 5,836B EV / Sales 2026 *
3.57x
EV / Sales 2027 * 3.25x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.18%
1 week-3.56%
Current month-6.38%
1 month+5.01%
3 months+12.43%
6 months+8.75%
Current year+14.93%
1 week 198.93
Extreme 198.93
219.02
1 month 193.2
Extreme 193.195
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
282.74
5 years 110.04
Extreme 110.035
372.12
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-3.56%+50.43%-28.17% 30.37B
-1.74%+6.13%+21.04%-5.74% 68.8B
-2.01%-3.57%+46.21%+217.06% 55.21B
-4.15%+36.30%+36.30%+36.30% 43.46B
+0.27%+8.33%-49.87%-53.43% 41.18B
-6.98%+3.40%+130.38%-39.10% 31.65B
-1.06%+2.50%+72.38%+88.48% 23.58B
-1.15%+8.29%+4.42%+184.96% 19.33B
-1.33%+1.11%+66.11%+131.83% 17.16B
-0.71%+3.78%+79.07%+345.51% 15.27B
Average -1.99%+3.83%+45.65%+87.77% 34.6B
Weighted average by Cap. -2.12%+3.59%+38.48%+63.80%

Financials

2026 *2027 *
Net sales 10.05B 8.82B 8.14B 7.52B 14.25B 962B 14.54B 97.84B 38.01B 471B 37.74B 36.92B 1,635B 10.39B 9.11B 8.41B 7.77B 14.73B 994B 15.02B 101B 39.28B 487B 39B 38.15B 1,689B
Net income 1.52B 1.34B 1.23B 1.14B 2.16B 146B 2.2B 14.82B 5.76B 71.33B 5.72B 5.59B 248B 1.97B 1.73B 1.59B 1.47B 2.79B 189B 2.85B 19.17B 7.45B 92.26B 7.39B 7.23B 320B
Net Debt 5.51B 4.83B 4.46B 4.12B 7.81B 527B 7.97B 53.63B 20.84B 258B 20.69B 20.23B 896B 3.38B 2.97B 2.74B 2.53B 4.8B 324B 4.9B 32.95B 12.8B 159B 12.71B 12.43B 551B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
09/07/26 USD 203.60 -1.02% 952,994
07/07/26 USD 205.70 -1.32% 1,156,880
06/07/26 USD 208.46 -3.54% 1,218,492
02/07/26 USD 216.12 +3.04% 1,155,165
01/07/26 USD 209.74 -2.93% 1,138,639
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
205.70USD
Average target price
222.38USD
Spread / Average Target
+8.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock